Riskpilot← Back to searchSign inGet full accessPERPETEIA AS
ASActiveOrg 990975647Kirkevegen 2, 2340 LøtenMedical specialists activities · NACE 8622Est. 20070 employees
Revenue 2024
NOK 0
EBITDA margin
—
+22% vs 2023
Equity ratio
—
Financial strength
Net profit 2024
NOK -25K
-17% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -17K | +22% |
| Net profit | NOK -25K | -17% |
| Total assets | NOK 0 | — |
| Equity | NOK -170K | -17% |
| Employees | 0 | — |
Legal name
PERPETEIA AS
Org number
990975647
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
1. januar 2007
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investeringsvirksomhet i medisinsk forskning, medisinsk informasjon, medisinske firmaer, og i helsefremmende produkter for dyr og mennesker. Dessuten drive med kjøp og salg av eiendom, samt kjøp og salg av selskapsandeler.
Address
Kirkevegen 2, 2340 Løten
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −16 | −17 | −11 | −22 | −17 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −16 | −17 | −11 | −22 | −17 |
| Net financials | 0 | −1 | 0 | 0 | −8 |
| Profit before tax | −16 | −18 | −11 | −22 | −25 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −16 | −18 | −11 | −22 | −25 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 0 | 0 |
| Equity | −646 | −664 | −123 | −145 | −170 |
| Long-term debt | 641 | 651 | 0 | 0 | 0 |
| Short-term debt | 4 | 13 | 123 | 145 | 170 |
| Total debt | 646 | 664 | 123 | 145 | 170 |
EBITDA margin
-1694400.0%
This company
15.8%
Market median
-10724151% vs market
20202024
Equity ratio
-17033000.0%
This company
38.2%
Market median
-44589105% vs market
20202024
Return on equity
-2533000.0%
This company
18.4%
Market median
-13766404% vs market
20202024
Net profit margin
-2533000.0%
This company
8.1%
Market median
-31271705% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
GH Deputy Member | Deputy Member | 2016 – 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PERPETEIA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Harald Wicklund | Deputy Member | 0 companies |
| Geir Grimsmo | Chairman | 0 companies |